Duloxetine Versus Paroxetine for Major Depression
NCT00489775 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 480
Last updated 2007-06-21
Summary
To determine if duloxetine works just as well as paroxetine in the treatment of major depressive disorder.
Conditions
Interventions
- DRUG
-
Duloxetine
- DRUG
-
Paroxetine
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-31
- Completion
- 2005-06-30
Countries
- China
Study Locations
More Related Trials
-
Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
NCT00036309 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
NCT00849901 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Desvenlafaxine in Treating Major Depressive Disorder.
NCT04364997 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
NCT00042562 ·Status: COMPLETED ·Phase: PHASE3
-
Switching to Duloxetine in Patients With Depression
NCT00696774 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms
NCT01000805 ·Status: COMPLETED ·Phase: PHASE4
-
Duloxetine in the Treatment of Melancholic Depression
NCT00191685 ·Status: COMPLETED ·Phase: PHASE3
-
A Local Register Study For Major Depression Of Paroxetine Controlled Release
NCT00368303 ·Status: COMPLETED ·Phase: PHASE3
-
An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
NCT00629551 ·Status: COMPLETED ·Phase: PHASE3
-
MDD POC Study GSK372475 Subjects Depressive Disease
NCT00420641 ·Status: COMPLETED ·Phase: PHASE2
-
Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression
NCT00494377 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
NCT00437125 ·Status: COMPLETED ·Phase: PHASE4
-
Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults
NCT01140906 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Depression and Associated Painful Physical Symptoms
NCT01070329 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
NCT01153009 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder
NCT00191061 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression
NCT02229825 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
NCT00666757 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
NCT00849693 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
NCT00422162 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Of New Medicine (GSK 372475) For The Treatment Of Depression
NCT00448058 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
NCT00406848 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Paroxetine and Duloxetine on Cardiovascular Measures
NCT00136383 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder
NCT07253207 ·Status: COMPLETED ·Phase: PHASE3
-
Major Depressive Disorder Study In Adults
NCT00049972 ·Status: COMPLETED ·Phase: PHASE4